
George Lundberg, MD Editor in Chief at Cancer Commons
-
February 20, 2021
Patients with Cancer Less Likely to Enroll in Clinical Trials Due to COVID-19 Bookmark
George Lundberg, MDFewer patients with cancer may be willing to enter a clinical trial. This Cancer Network article explains why and offers solutions.
.
-
February 20, 2021
NCI-Supported Clinical Trials for Coronavirus Bookmark
George Lundberg, MDThis list from the National Cancer Institute outlines many government-supported clinical trials for COVID-19 that may be specifically for cancer survivors.
.
-
February 20, 2021
What Cancer Survivorship Can Teach Us About COVID-19 Bookmark
George Lundberg, MDCancer survivors and (especially long) COVID-19 survivors may have a lot in common, as outlined in this opinion piece from STAT.
.
-
February 20, 2021
Patient education: Pancreatic cancer (Beyond the Basics) Bookmark
George Lundberg, MDUpToDate provides an authoritative overview of pancreatic cancer diagnosis and treatment.
.
-
February 20, 2021
Treatment of Stage IV- Metastatic or Recurrent Colon Cancer Bookmark
George Lundberg, MDThis CancerConnect article summarizes the latest treatment options for stage IV colorectal cancer.
.
-
February 20, 2021
Ovarian Cancer Research Alliance: For Patients Bookmark
George Lundberg, MDLiving with ovarian cancer may require many adaptations. This respected organization can help. Learn about their comprehensive resources for patients.
.
-
February 19, 2021
Renal Cell Carcinoma—An Overview Bookmark
George Lundberg, MDCurated by Editor in Chief George Lundberg, MD, who notes:
There are now many precision oncology treatments for the most common type of kidney cancer, renal cell carcinoma, which represents about 3% of all potentially lethal cancers in America. This summary from Medscape details all the traditional treatment approaches, as well as newer considerations.
.
-
January 29, 2021
Efficacy and Safety of Sorafenib Plus Vitamin K Treatment for Hepatocellular CarcinomA: A Phase II, Randomized Study Bookmark
George Lundberg, MDThis scientific research paper published in the journal Cancer Medicine reports that the drug sorafenib has shown some effectiveness against hepatocellular carcinoma in a clinical trial, and that adding vitamin K2 enhanced that effectiveness.
.
-
January 29, 2021
Targeted Therapy for Hepatocellular Carcinoma Bookmark
George Lundberg, MDThis scientific review paper published in the journal Signal Transduction and Targeted Therapy discusses recent research into newer medications that show promise as targeted therapies for some cases of primary hepatocellular carcinoma, following molecular testing.
.
-
January 29, 2021
Advice from the Brain Tumor Community Bookmark
George Lundberg, MDNCI-CONNECT shares insights from patients, caregivers, doctors, and advocates with the aim to help you manage your life—regardless of your brain cancer diagnosis.
.